Zenas BioPharma Inc. (ZBIO)
ZBIO trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$25.16
-4.70% on the day
Market cap
$1.6B
Small cap
Revenue · 2025
$10.0M
+100.0% on 2024
Net income · 2025
-$377.7M
-3777.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ZBIO on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2024 |
| SEC CIK | 0001953926 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $10.0M |
| Net income | -$377.7M |
| Operating income | -$383.1M |
| Net margin | -3777.4% |
| Operating margin | -3830.6% |
| Revenue growth | +100.0% |
| Cash | $110.6M |
| Total assets | $383.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 164.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2026-09-11 |
| Latest annual report | 10-K | 2026-03-16 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report FORM 8-K | 8-K | 2026-10-13 |
| Latest proxy | DEFA14A | 2026-03-16 |
Source: SEC EDGAR submissions feed, 189 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -12.2% |
| 1 month | -22.5% |
| 3 months | -12.4% |
| Year to date | -31.9% |
| 1 year | -6.8% |
| From 52-week high | -42.7% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ANIP | ANI Pharmaceuticals Inc. | $70.84 | -3.74% | $1.6B |
| NUVB | Nuvation Bio Inc. | $4.72 | -3.67% | $1.7B |
| GPCR | Structure Therapeutics Inc. | $22.31 | -6.69% | $1.6B |
| OCUL | Ocular Therapeutix Inc. | $7.24 | -4.23% | $1.6B |
| MRVI | Maravai LifeSciences Holdings Inc. | $6.53 | -7.51% | $1.7B |
| SEPN | Septerna Inc. | $36.41 | -3.05% | $1.7B |
| GENB | Generate Biomedicines Inc. | $12.26 | -11.45% | $1.6B |
| BHVN | Biohaven Ltd. Common Shares | $11.42 | -3.30% | $1.7B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier